Multiple-Dose Pharmacokinetic Behavior of Elvucitabine, a...

Multiple-Dose Pharmacokinetic Behavior of Elvucitabine, a Nucleoside Reverse Transcriptase Inhibitor, Administered over 21 Days with Lopinavir-Ritonavir in Human Immunodeficiency Virus Type 1-Infected Subjects

Colucci, P., Pottage, J. C., Robison, H., Turgeon, J., Schurmann, D., Hoepelman, I. M., Ducharme, M. P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
53
Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.00907-08
Date:
February, 2009
File:
PDF, 519 KB
english, 2009
Conversion to is in progress
Conversion to is failed